[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100616509":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":48,"collaborators":19,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":19,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":19,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Jamia Millia Islamia","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Inferior Alveolar Nerve Block","EXPERIMENTAL","Patients will receive a standard inferior alveolar nerve block using 1.5 mL of 2% lidocaine with 1:80,000 epinephrine. The efficacy of anesthesia will be evaluated by two measures. First, pulpal anesthesia will be assessed using a cold test with Endo-Ice. Second, intraoperative pain will be recorded during access cavity preparation using the Heft-Parker Visual Analog Scale (HPVAS). Anesthetic outcome will be classified as either success or failure. Success will be defined as absence of response to cold testing along with no or only mild intraoperative pain (HPVAS ≤ 54 mm).",[13],"Procedure: Inferior Alveolar Nerve Block",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"PROCEDURE","The patients will receive a standard inferior alveolar nerve block using 1.5 mL of 2% lidocaine with 1:80,000 epinephrine. The efficacy of anesthesia will be evaluated by two measures. First, pulpal anesthesia will be assessed using a cold test with Endo-Ice. Second, intraoperative pain will be recorded during access cavity preparation using the Heft-Parker Visual Analog Scale (HPVAS). Anesthetic outcome will be classified as either success or failure. Success will be defined as absence of response to cold testing along with no or only mild intraoperative pain (HPVAS ≤ 54 mm).",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Vivek Aggarwal, MDS","CONTACT","+919818188358","vaggarwal@jmi.ac.in",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Faculty of Dentistry, JMI","RECRUITING","New Delhi","Delhi(दिल्ली)","110025","India","IN",{"type":36,"coordinates":37},"Point",[38,39],77.2148,28.62137,{"lat":39,"lon":38},[42,45,46],{"name":43,"role":23,"phone":44,"phoneExt":19,"email":25},"Vivek Aggarwal","09818188358",{"name":19,"role":23,"phone":19,"phoneExt":19,"email":25},{"name":22,"role":47,"phone":19,"phoneExt":19,"email":19},"PRINCIPAL_INVESTIGATOR",{"type":47,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Dr. Vivek Aggarwal","Professor","100616509","effect-of-menstrual-phase-on-the-anesthetic-efficacy-100616509",false,"NCT07306533","Effect of Menstrual Phase on the Anesthetic Efficacy","Effect of Menstrual Phase on the Anesthetic Efficacy of Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars","Inclusion Criteria\n\n* Female patients aged 20-40 years.\n* Regular menstrual cycles (28 ± 3 days).\n* Diagnosed with symptomatic irreversible pulpitis in mandibular molars.\n* Indicated for root canal therapy.\n* Willing to provide informed consent. Exclusion Criteria\n* Use of oral contraceptives or hormonal therapy.\n* Irregular menstrual cycles.\n* Pregnancy or lactation.\n* Systemic disease affecting pain perception (e.g., diabetes, neuropathies).\n* Recent use of analgesics or sedatives (within 24 hours).\n* Allergy to local anesthetics.","FEMALE","18 Years","45 Years",{"count":62,"type":63},150,"ESTIMATED","INTERVENTIONAL",[66],"NA","The goal of this observational prospective clinical study is to learn whether the menstrual phase influences the anesthetic efficacy of inferior alveolar nerve block (IANB) in female patients aged 20-40 years with symptomatic irreversible pulpitis in mandibular molars. The main questions it aims to answer are:\n\nDoes the success rate of IANB vary across different phases of the menstrual cycle?\n\nAre certain menstrual phases associated with a higher likelihood of anesthetic failure during endodontic access preparation?\n\nResearchers will compare five menstrual phase groups (menstrual, follicular, ovulatory, luteal, and premenstrual) to see if hormonal fluctuations affect anesthetic success.\n\nParticipants will:\n\nReceive a standardized inferior alveolar nerve block using 2% lidocaine with 1:80,000 epinephrine\n\nUndergo cold testing and access cavity preparation to assess anesthetic success\n\nHave intraoperative pain recorded using the Heft-Parker Visual Analog Scale (HPVAS), with menstrual phase information recorded confidentially and blinded to the treating clinician",[69],"Pulpitis - Irreversible",[71,72,73],"IANB","pulpitis","anesthesia","2025-12-25",{"date":76,"type":77},"2025-12-29","ACTUAL",{"date":79,"type":77},"2025-09-11",{"date":81,"type":63},"2026-03-10",{"name":5,"class":6},1]